← Snapshot 21

Orange Book snapshot 21: Products

Products page 99 of 799 · 39,901 matching rows.

Source row, Application type, Application number table
Source rowApplication typeApplication numberProduct numberIngredient rawDosage form / route rawDosage formRouteTrade nameApplicantStrength rawTE rawTE JSONApproval dateApproval date rawApproved before 1982RLDRSProduct typeApplicant full nameRaw row SHA-256
4902A206651003TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSBELCHEREQ 5MG BASEAB["AB"]2017-11-30Nov 30, 2017NoNoNoRXBELCHER PHARMACEUTICALS LLC71ae2c936221b1c90b62b96cc5ece87097985e2f3fc5adb6c8d0bff5683be93f
4903A212297001TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSBIOCON PHARMAEQ 0.5MG BASEAB["AB"]2020-11-10Nov 10, 2020NoNoNoRXBIOCON PHARMA LTD6ac2506b3ed98c32ce8c6d4cdba7b40b2c7bd96bc936803c8f7478ff7d958249
4904A212297002TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSBIOCON PHARMAEQ 1MG BASEAB["AB"]2020-11-10Nov 10, 2020NoNoNoRXBIOCON PHARMA LTDe88a901a52064846325cd8f07de5e1ff55fc49eb826a927de4e8329c4cd7c17a
4905A212297003TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSBIOCON PHARMAEQ 5MG BASEAB["AB"]2020-11-10Nov 10, 2020NoNoNoRXBIOCON PHARMA LTDa1aa0e46cf8f271c67f9db0a4cef46a39dc042ba5af555b03d19e8c692784d5f
4906A213112001TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSCONCORD BIOTECH LTDEQ 0.5MG BASEAB["AB"]2020-11-10Nov 10, 2020NoNoNoRXCONCORD BIOTECH LTD2427f5bd10564402767fdfd0f679b1b465c6fe4a4ae79f60b65b6189ef41f863
4907A213112002TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSCONCORD BIOTECH LTDEQ 1MG BASEAB["AB"]2020-11-10Nov 10, 2020NoNoNoRXCONCORD BIOTECH LTD76fa0a04cf4d620a6bc034f3c59a77100b0e33af5454f7d9ac50320a7c453b99
4908A213112003TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSCONCORD BIOTECH LTDEQ 5MG BASEAB["AB"]2020-11-10Nov 10, 2020NoNoNoRXCONCORD BIOTECH LTD80b607e0cafd36a48283180c891e5d60f0a7405975b31f3e4f02af18a77d96dd
4909A090509001TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSDR REDDYS LABS LTDEQ 0.5MG BASEAB["AB"]2010-05-12May 12, 2010NoNoNoRXDR REDDYS LABORATORIES LTD45a3acec36696ad555b492ac3095cd185e97bb3a67abd7ced49a1ff1b2150bd4
4910A090509002TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSDR REDDYS LABS LTDEQ 1MG BASEAB["AB"]2010-05-12May 12, 2010NoNoNoRXDR REDDYS LABORATORIES LTD6c4cd4780a3235094657b789ec64395fc25d6d064813d3f6663a944a4049c322
4911A090509003TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSDR REDDYS LABS LTDEQ 5MG BASEAB["AB"]2010-05-12May 12, 2010NoNoNoRXDR REDDYS LABORATORIES LTD1a42a873e9ff660330336b0e15042d30460f95a9d19d1deb10a16dd100b5179a
4912A206662001TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSGLENMARK PHARMS LTDEQ 0.5MG BASEAB["AB"]2020-11-10Nov 10, 2020NoNoNoRXGLENMARK PHARMACEUTICALS LTD6867699fa1e22fd322004ee973abc2f9f302b932d51052e7e515c51c4d32f48b
4913A206662002TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSGLENMARK PHARMS LTDEQ 1MG BASEAB["AB"]2020-11-10Nov 10, 2020NoNoNoRXGLENMARK PHARMACEUTICALS LTDd2d339c6a918f14eab62ac85297559139123a55d08f5e77b0b542c4533bcce6c
4914A206662003TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSGLENMARK PHARMS LTDEQ 5MG BASEAB["AB"]2020-11-10Nov 10, 2020NoNoNoRXGLENMARK PHARMACEUTICALS LTD3fde916a0b9981ee233ffaa0a998f17cba7a88f4e76ab67eac551fc259613e25
4915A090402001TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSHERITAGE PHARMAEQ 5MG BASE[]2010-07-01Jul 1, 2010NoNoNoDISCNHERITAGE PHARMA LABS INCda6adcf60026ac089a9ee475348abca1c50ab91571748bbf7ca3cd31c181db45
4916A090596001TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSMYLANEQ 0.5MG BASEAB["AB"]2010-09-17Sep 17, 2010NoNoNoRXMYLAN PHARMACEUTICALS INC2f82f0f244b9e69b35594a1d92282c9f311fa71cfabdd7a57e87d99a4bd2b085
4917A090596002TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSMYLANEQ 1MG BASEAB["AB"]2010-09-17Sep 17, 2010NoNoNoRXMYLAN PHARMACEUTICALS INCc3058d98def6ec2cdfc37765ae6adf4bac9fbbec19b388c0c68b71c39ea1eff6
4918A090596003TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSMYLANEQ 5MG BASEAB["AB"]2010-09-17Sep 17, 2010NoNoNoRXMYLAN PHARMACEUTICALS INCd235144f767422d0dd20dd18e47293d5dbd6d6141478d5573626a8a6c703a201
4919A090802001TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSPANACEA BIOTEC LTDEQ 0.5MG BASEAB["AB"]2012-09-28Sep 28, 2012NoNoNoRXPANACEA BIOTEC LTD2579f500677c9987e3819881341c7ecad19b9e1f1b33a913461be2295e183f0f
4920A090802002TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSPANACEA BIOTEC LTDEQ 1MG BASEAB["AB"]2012-09-28Sep 28, 2012NoNoNoRXPANACEA BIOTEC LTD77a283b39167ef8c6064455a51fe91ea41dfef8bedd3948a498bb509abf48a0f
4921A090802003TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSPANACEA BIOTEC LTDEQ 5MG BASEAB["AB"]2012-09-28Sep 28, 2012NoNoNoRXPANACEA BIOTEC LTD8494b27a26a9725b9648a2bde90a79e23362a90107c3ddda19fb0a057a780cd6
4922A065461001TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSSANDOZEQ 0.5MG BASEAB["AB"]2009-08-10Aug 10, 2009NoNoNoRXSANDOZ INC48016a4485e05b142893687caca64d6154b036786b0e3487414b2a9d39a03cf0
4923A065461002TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSSANDOZEQ 1MG BASEAB["AB"]2009-08-10Aug 10, 2009NoNoNoRXSANDOZ INCcecb01f75870abb7abf89c04c244b6ef4bada4968ab9715f255ebd83eda023df
4924A065461003TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSSANDOZEQ 5MG BASEAB["AB"]2009-08-10Aug 10, 2009NoNoNoRXSANDOZ INCd5244f68f2451d50f1a95426d180c75e3cbd493381716863d053cbf4d3c0e009
4925A090687001TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSSTRIDES PHARMAEQ 0.5MG BASEAB["AB"]2014-07-22Jul 22, 2014NoNoNoRXSTRIDES PHARMA GLOBAL PTE LTD5b8dc766ca4767f03c1097431f496f782564e2aaf9caf6fb913781315767f5d7
4926A090687002TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSSTRIDES PHARMAEQ 1MG BASEAB["AB"]2014-07-22Jul 22, 2014NoNoNoRXSTRIDES PHARMA GLOBAL PTE LTD07573f31e37fc52d2645202cde5f021194871acbd30152036636b402b94e35c4
4927A090687003TACROLIMUSCAPSULE;ORALCAPSULEORALTACROLIMUSSTRIDES PHARMAEQ 5MG BASEAB["AB"]2014-07-22Jul 22, 2014NoNoNoRXSTRIDES PHARMA GLOBAL PTE LTDace793c4c75885978d4d7cf78748bd81f908b6aa988ce13c73423d2a15b9b83d
4928N202806001DABRAFENIB MESYLATECAPSULE;ORALCAPSULEORALTAFINLARNOVARTISEQ 50MG BASE[]2013-05-29May 29, 2013NoYesNoRXNOVARTIS PHARMACEUTICALS CORP87c3a8401c64f61a2fe61b6f71f2cad37545396e0bcc815508c599e7e562a198
4929N202806002DABRAFENIB MESYLATECAPSULE;ORALCAPSULEORALTAFINLARNOVARTISEQ 75MG BASE[]2013-05-29May 29, 2013NoYesYesRXNOVARTIS PHARMACEUTICALS CORPd9c59e23d15a1644be0aed9c80ffcd907377dcb448c802a3735157c9575d3b7f
4930N211651001TALAZOPARIB TOSYLATECAPSULE;ORALCAPSULEORALTALZENNAPFIZEREQ 0.25MG BASE[]2018-10-16Oct 16, 2018NoYesNoRXPFIZER INC645eaa7a671a67ce19da45fa7cbeb54f744b98bc0578b0cb18ed5608c76cbfa9
4931N211651002TALAZOPARIB TOSYLATECAPSULE;ORALCAPSULEORALTALZENNAPFIZEREQ 1MG BASE[]2018-10-16Oct 16, 2018NoYesYesRXPFIZER INCa93a00484670d9f98932a5187d849e30ee7b452cde82567f1b346bd350cba3ca
4932N021087003OSELTAMIVIR PHOSPHATECAPSULE;ORALCAPSULEORALTAMIFLUROCHEEQ 30MG BASEAB["AB"]2007-07-02Jul 2, 2007NoYesNoRXHOFFMANN LA ROCHE INC30adf0630513ca83a2d53d368e2aba6a92213bb7e1e18dc6068128285b3d8944
4933N021087002OSELTAMIVIR PHOSPHATECAPSULE;ORALCAPSULEORALTAMIFLUROCHEEQ 45MG BASEAB["AB"]2007-07-02Jul 2, 2007NoYesNoRXHOFFMANN LA ROCHE INCf40367d121fca3995499cfda395157861528ba7cd0b313d5e39b219056d9d14c
4934N021087001OSELTAMIVIR PHOSPHATECAPSULE;ORALCAPSULEORALTAMIFLUROCHEEQ 75MG BASEAB["AB"]1999-10-27Oct 27, 1999NoYesYesRXHOFFMANN LA ROCHE INC2611b17685607da781caf39f2c36e1f2904df129635f15a4df6df27502382b71
4935A207405001TAMSULOSIN HYDROCHLORIDECAPSULE;ORALCAPSULEORALTAMSULOSIN HYDROCHLORIDEALKEM LABS LTD0.4MGAB["AB"]2017-08-11Aug 11, 2017NoNoNoRXALKEM LABORATORIES LTDf61f803d7d835b7f243a297a412d6b39bf763da9b156c7532161784044eea72e
4936A211885001TAMSULOSIN HYDROCHLORIDECAPSULE;ORALCAPSULEORALTAMSULOSIN HYDROCHLORIDEANBISON LAB0.4MG[]2019-10-17Oct 17, 2019NoNoNoDISCNANBISON LABORATORY CO LTDc1d55555ede8246af49215bab80d494da170ae0b6af6aee771f3ea43012f6dfd
4937A202010001TAMSULOSIN HYDROCHLORIDECAPSULE;ORALCAPSULEORALTAMSULOSIN HYDROCHLORIDEANCHEN PHARMS0.4MGAB["AB"]2013-01-04Jan 4, 2013NoNoNoRXANCHEN PHARMACEUTICALS INC290e14e4eb6f335076dd47c8dae4c3d85ca1bc4e55120d170302ef9610a55fad
4938A202433001TAMSULOSIN HYDROCHLORIDECAPSULE;ORALCAPSULEORALTAMSULOSIN HYDROCHLORIDEAUROBINDO PHARMA LTD0.4MGAB["AB"]2013-04-30Apr 30, 2013NoNoNoRXAUROBINDO PHARMA LTD7bb868e0e4c99c8704e565216f95ea538c4bc61e39a153db69d419ea81bc7b7d
4939A090377001TAMSULOSIN HYDROCHLORIDECAPSULE;ORALCAPSULEORALTAMSULOSIN HYDROCHLORIDEIMPAX LABS0.4MGAB["AB"]2010-03-02Mar 2, 2010NoNoNoRXIMPAX LABORATORIES INC1edf8b425ec147fe25547570fa94f98b26ca8f21bc5b33df4de7fbe16d58709a
4940A204645001TAMSULOSIN HYDROCHLORIDECAPSULE;ORALCAPSULEORALTAMSULOSIN HYDROCHLORIDEMACLEODS PHARMS LTD0.4MGAB["AB"]2017-01-20Jan 20, 2017NoNoNoRXMACLEODS PHARMACEUTICALS LTDb869809b3324132063e347221dc7a5ed7ecfc02fd56b28ebe70d260d7cda9c53
4941A090408001TAMSULOSIN HYDROCHLORIDECAPSULE;ORALCAPSULEORALTAMSULOSIN HYDROCHLORIDEMYLAN0.4MG[]2010-04-27Apr 27, 2010NoNoNoDISCNMYLAN PHARMACEUTICALS INCef645794760c581f8fe3bcda0d96bfa50b8f50a24e677804e5704fd509e2292c
4942A078015001TAMSULOSIN HYDROCHLORIDECAPSULE;ORALCAPSULEORALTAMSULOSIN HYDROCHLORIDESANDOZ0.4MGAB["AB"]2010-04-27Apr 27, 2010NoNoNoRXSANDOZ INCae91e6f1379eb15ed3e447434a56a006e7ebfc696cac2a660b80f76a1fffbbff
4943A090931001TAMSULOSIN HYDROCHLORIDECAPSULE;ORALCAPSULEORALTAMSULOSIN HYDROCHLORIDESUN PHARM INDS LTD0.4MGAB["AB"]2010-07-15Jul 15, 2010NoNoNoRXSUN PHARMACEUTICAL INDUSTRIES LTD7733de4d477a3da325c24e1f5fee37a2cea533ac3edb765f168fd2f31cb83068
4944A078801001TAMSULOSIN HYDROCHLORIDECAPSULE;ORALCAPSULEORALTAMSULOSIN HYDROCHLORIDESYNTHON PHARMS0.4MGAB["AB"]2010-04-27Apr 27, 2010NoNoNoRXSYNTHON PHARMACEUTICALS INC15ea106bae384388d1daeeec54bf90ad91c158e7da8254fd509a5b5a38153120
4945A077630001TAMSULOSIN HYDROCHLORIDECAPSULE;ORALCAPSULEORALTAMSULOSIN HYDROCHLORIDETEVA PHARMS0.4MGAB["AB"]2010-04-27Apr 27, 2010NoNoNoRXTEVA PHARMACEUTICALS USAf9463aa2e6b72dbb30de6c9390ab9b37ef7490499dc8eb9d03361ac858fb541f
4946A078938001TAMSULOSIN HYDROCHLORIDECAPSULE;ORALCAPSULEORALTAMSULOSIN HYDROCHLORIDEWOCKHARDT0.4MGAB["AB"]2010-04-27Apr 27, 2010NoNoNoRXWOCKHARDT LTD6e439d4f3e590f895c53efc3f77852817f59de3d57c2e31b0534dc8299414fac
4947A078225001TAMSULOSIN HYDROCHLORIDECAPSULE;ORALCAPSULEORALTAMSULOSIN HYDROCHLORIDEZYDUS PHARMS USA INC0.4MGAB["AB"]2010-04-27Apr 27, 2010NoNoNoRXZYDUS PHARMACEUTICALS USA INC16ab41b10ac6c5c24ac6ca9b1dbd5352222f9960a7905104de1ed5103ae50d0a
4948N050336002TROLEANDOMYCINCAPSULE;ORALCAPSULEORALTAOPFIZEREQ 250MG BASE[]Approved Prior to Jan 1, 1982YesNoNoDISCNPFIZER PHARMACEUTICALS INC09ddc8a29a1e70d0ece1e33b75afe914ac66899624ad12e49399d7307a5d24ee
4949N021055001BEXAROTENECAPSULE;ORALCAPSULEORALTARGRETINVALEANT LUXEMBOURG75MGAB["AB"]1999-12-29Dec 29, 1999NoYesYesRXVALEANT PHARMACEUTICALS LUXEMBOURG SARLcc95679c219a9007b53cb852d9295f16af2f155fc82b050081e6eba179ec84a9
4950N022068003NILOTINIB HYDROCHLORIDECAPSULE;ORALCAPSULEORALTASIGNANOVARTISEQ 50MG BASE[]2018-03-22Mar 22, 2018NoYesNoRXNOVARTIS PHARMACEUTICALS CORP856629f0b083c70f4f412bc35fb5607b7130c85d45e05a33faab3db6e8c2ea7b
4951N022068002NILOTINIB HYDROCHLORIDECAPSULE;ORALCAPSULEORALTASIGNANOVARTISEQ 150MG BASE[]2010-06-17Jun 17, 2010NoYesNoRXNOVARTIS PHARMACEUTICALS CORP3dd119f87f8039e29bf1d235c0a346b2fb451615880b17f122d5967601fe62de